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Introduction 
 
Juvenile ossifying fibroma (JOF) is a rare fibro-osseous lesion of the craniofacial skeleton occurring 
predominantly in children [1]. Two separate entities, psammomatoid juvenile ossifying fibroma 
(PsJOF) and trabecular juvenile ossifying fibroma (TrJOF) are described in the literature [2]. 
Microscopically, the tumor consists of a cellular fibrous stroma and of a mineralized osseous 
component in either a psammomatoid or a trabecular pattern [3]. PsJOF is the more frequently 
reported subtype and involves primarily the bones of the paranasal sinuses and of the orbit [4-5]. In 
contrast, TrJOF almost exclusively affects the mandible or the maxilla, tends to occur in younger 
patients and is characterized by a less favorable clinical behavior with a locally aggressive growth 
pattern and a high rate of recurrence [2]. Therefore, it is also termed juvenile aggressive fibroma. 
Usually, TrJOF presents as a painless swelling of the jaw bones and leads to facial asymmetry [6]. 
Surgery is the mainstay of therapy, but due to the infiltration of the surrounding tissue, the tumor 
often cannot be shelled out in its entirety and has a high rate of recurrence.  To our knowledge, we 
describe the first case of TrJOF of the sella turcica. 
 
 
 
 
 
 
 
3 
 
Case Report 
 
A 15 year old female presented with a 4 week history of diplopia, anisocoria (mild mydriasis on the 
left), mild ptosis on the left eye, and frontal pressure-type headaches. She was initially seen by an 
ophthalmologist who referred her with the diagnosis of left occulomotor nerve palsy to the 
Children’s Hospital for further examination. Preoperative imaging showed a contrast-enhancing 
space occupying lesion (4x3x2cm) of the sellar region with extension into the cavernous sinus 
bilaterally and compression of the optic chiasm (figure 1). The sphenoid sinus was filled with tumor 
and the bony structures of the dorsum sellae and the superior aspect of the clivus were infiltrated by 
the lesion. Endocrinologic work-up revealed partial hypogonadotropic hypogonadism with primary 
amenorrhea and pubertas tarda, but no inadequately elevated hormone levels. Initially, a non-
secretory macroadenoma of the pituitary gland was suspected and a transsphenoidal resection with 
intra-OP MR imaging (ioMRI) (PoleStar N20, 0.15 T, Medtronic Navigation) was performed. 
Intraoperatively, this solid lesion appeared white-grayish and had a rough cartilaginous consistency. 
Tissue samples from this procedure, as decribed below in more detail, were classified as trabecular 
juvenile ossifying fibroma. Definitive diagnosis was delayed due to the request for second and third 
opinions from external pathologists. Four weeks after the first resection follow-up MRI showed 
residual tumor (figure 3) and a second procedure using a combined transsphenoidal and pterional 
approach with ioMRI was performed (figure 2).  This time, a nearly gross total resection has been 
accomplished as shown by the follow-up MRI scans (figure 3). The postoperative course was 
uneventful and the patient’s symptoms (especially anisocoria, ptosis and headaches) started to 
improve during the first post-operative weeks. In accordance with the management 
recommendations by the hospital’s interdisciplinary neurooncology tumor board, the patient 
underwent proton radiotherapy at the Swiss Paul Scherrer Institute. A total dose of 59.4 Gy(RBE) was 
delivered postoperatively in 33 daily treatment fractions. Double vision improved significantly after 
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proton radiotherapy. Clinical follow-up and re-imaging (figure 3) 12 months after her initial 
presentation revealed largely resolved ocular symptoms, unimpaired olfaction, and no headaches. 
Her endocrinologic follow-up showed the hormone levels seen in table 1. She reports no new 
symptoms and is participating in school with no problems.  
 
Histology 
Histological examination revealed a cell-rich neoplasm consisting predominantly of fibroblastic cells. 
The cells were located in a partly fibrous, partly compact-appearing, eosinophilic matrix (figures 4 
and 5). Elastica van Gieson staining detected a net-like structure (figure 6), which became compact in 
some areas forming immature osteoid. The neoplastic cells were spindle-shaped to oval and some 
giant cells could be found. Immunohistochemical staining of the cells and the matrix surrounding the 
trabecular structures was positive for Procollagen 1. Additionally, the cells stained positive for 
Osterix, a transcription factor known to be expressed in osteoblasts. 
The typical histological features of trabecular juvenile ossifying fibroma are aggregates of giant cells 
in a cell-rich fibrous stroma containing bundles of cellular osteoid and bone trabeculae without 
osteoblastic rimming [7].  
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Discussion  
Although TrJOF represents a rare fibro-osseous lesion, early management decisions anticipating the 
clinical behavior of those lesions should be made, for they might be histologically benign, but locally 
aggressive as in this case. For that reason, most aggressive tumor removal as soon as possible is 
critical. In addition, this case also highlights the suitability of ioMRI since the degree of resection is of 
major importance, especially if the tumor infiltrates delicate structures like the cavernous sinus. The 
advantages of ioMRI were already addressed in other tumor entities [8-9] and also showed a benefit 
in the grade of resection in this patient. 
Radiation therapy is generally not employed in the primary management of these essentially non-
malignant lesions for justified concerns of late damaging effects to developing normal tissues and 
induction of malignancy later in life. However, precision radiotherapy has been used for a variety of 
benign, but locally aggressive mesenchymal tumors in anatomic locations precluding complete, 
microscopic surgical resection and following recurrent growth [10]. Proton Radiotherapy has 
demonstrated its advantage of precise tumor targeting combined with maximum normal tissue 
sparing and is an accepted and often preferred radiotherapy modality in the treatment of pediatric, 
solid tumors [11].  Proton Radiotherapy permits delivery of higher radiation doses compared to 
conventional photon radiotherapy [12] . This maximizes chances for permanent local control given 
the difficulties of salvage surgery in case of recurrence in the same location. 
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Conclusion 
Trabecular juvenile ossifying fibroma is a locally-aggressive juvenile tumor mostly found 
extracranially. This is the first case of TrJOF mimicking a macroadenoma of the pituitary. Even though 
patients with such a diagnosis are rare, one should always consider a fibro-osseous lesion when 
dealing with a sellar mass. Treatment strategies should be interdisciplinary and should include an 
early, aggressive tumor removal. In this setting, ioMRI is a helpful tool to achieve a high degree of 
resection. Due to its precise tumor targeting, proton radiotherapy is an excellent modality in the 
treatment of these locally-challenging pediatric tumors. 
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FIGURES and TABLES 
 
Figure 1: pre-OP imaging.                                                                                                                                                            
First row:               MRI T1 with contrast                                                                                                                                  
Second row:          cCT with contrast                                                                                                                                               
Third row:       native T1- and T2-weighted images 
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Figure 2: intraoperative MRI scans (PoleStar N20, 0.15 T, Medtronic Navigation) of the combined 
procedure.  
a preoperative T1-weighted scan with contrast b T1-weighted scan with contrast after the 
transsphenoidal resection   
 
 
Figure 3: T1-weighted contrast enhanced follow-up imaging.  
a 4 weeks after the initial transsphenoidal procedure b after the combined approach c after proton 
therapy and 12 months after the combined approach 
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Figure 4: Microscopic image HE, x20. Cellular lesion containing giant cells and fibroblastic cells in a 
fibrous, eosinophilic matrix.  
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Figure 5: Microscopic Image HE, x20. The matrix is focally compacted to osteoid, resembling 
immature bone. At the lower right border, residual non-neoplastic bone can be seen.   
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Figure 6: Microscopic Image EVG, x20. Elastica van Gieson staining reveals a net-like structure of 
collagen fibers which is compacted to form immature osteoid in some areas. 
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Table 1: Endocrinologic data. *the patient received steroid therapy at that time 
hormone pre-OP post 2
nd
 OP 6 months 12 months  normal range 
TSH 1.62 mU/l 1.89 mU/l 2.12 mU/l 3.05 mU/l 0.53 - 3.59 mU/l 
fT4 17.6 pmol/l 13.1 pmol/l 14.6 pmol/l 13.4 pmol/l 12.0 - 20.6 pmol/l 
LH 10.7 IE/l 7.9 IE/l 11.9 IE/l 7.6 IE/l depending on age and menstrual 
cycle 
FSH 5.9 IE/l 3.2 IE/l 5.1 IE/l 7.7 IE/l depending on age and menstrual 
cycle 
prolactin 7.9 µg/l 5.8 µg/l 17.1 µg/l 23.4 µg/l 4.8 – 23.3 µg/l 
estradiol 188 pmol/l 85 pmol/l  197 pmol/l 93 pmol/l depending on age and menstrual 
cycle 
IGF1 293 µg/l 312 µg/l 289 µg/l 177 µg/l 226 – 903 µg/l 
cortisol 16 nmol/l 
*
 424 nmol/l 321 nmol/l  608 nmol/l 171 – 536 nmol/l 
 
 
